 |
市場調查報告書
商品編碼
1905306
日本藥局福利管理市場報告（按服務、商業模式、最終用途和地區分類，2026-2034 年）Japan Pharmacy Benefit Management Market Report by Service, Business Model, End Use, and Region 2026-2034 |
||||||
2025年，日本藥品福利管理市場規模達374.776億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到573.722億美元，2026年至2034年間的複合年成長率（CAGR）為4.85%。推動市場成長的主要因素包括對處方藥成本效益管理的日益成長的需求，以及機器學習（ML）和人工智慧（AI）技術的應用。
本報告解答的關鍵問題：
- 日本藥品福利管理市場目前表現如何？未來幾年又將如何發展？
- 新冠疫情對日本藥品福利管理市場產生了哪些影響？
- 日本藥品福利管理市場依服務類型分類的組成是怎樣的？
- 日本藥品福利管理市場依商業模式分類的組成是怎樣的？
- 日本藥品福利管理市場依最終用途分類的組成是怎樣的？
- 日本藥品福利管理市場價值鏈的各個階段有哪些？
- 日本藥品福利管理的關鍵促進因素和挑戰是什麼？
- 日本藥品福利管理市場的結構是怎麼樣的？主要參與者有哪些？
- 日本藥品福利管理市場的競爭程度如何？
目錄
第1章：序言
第2章：範圍與方法
- 研究目標
- 利害關係人
- 數據來源
- 市場估算
- 預測方法
第3章：執行概要
第4章：日本藥品福利管理市場－簡介
- 概述
- 市場動態
- 產業趨勢
- 競爭情報
第5章：日本藥品福利管理市場概況
- 歷史及當前市場趨勢（2020-2025）
- 市場預測（2026-2034）
第6章：日本藥品福利管理市場－依服務類型分類
- 專科藥局服務
- 藥物處方集管理
- 零售藥局服務
- 福利計劃設計與諮詢
- 疾病管理服務
- 其他
第7章：日本藥品福利管理市場－依商業模式分類
- 健康保險管理
- 獨立式PBM
- 零售藥房
第8章：日本藥品福利管理市場－依最終用途分類
- 聯邦
- 商業的
第9章：日本藥品福利管理市場－按地區分類
- 關東地區
- 關西/近畿地區
- 中部/中部地區
- 九州·沖繩地區
- 東北部地區
- 中國地區
- 北海道地區
- 四國地區
第10章：日本藥品福利管理市場－競爭格局
- 概述
- 市場結構
- 市場參與者定位
- 最佳制勝策略
- 競爭格局分析
- 公司評估象限
第11章：關鍵參與者簡介
第12章：日本藥品福利管理市場－產業分析
- 促進因素、限制因素和機遇
- 波特五力分析
- 價值鏈分析
第13章：附錄
Japan pharmacy benefit management market size reached USD 37,477.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 57,372.2 Million by 2034, exhibiting a growth rate (CAGR) of 4.85% during 2026-2034. The market is being driven by the increasing demand for cost-effective management of prescription medications and the incorporation of machine learning (ML) and artificial intelligence (AI) technologies.
Pharmacy benefit management (PBM) refers to the third-party entities that administer prescription drug programs on behalf of health insurance plans, employers, and other organizations. It plays a crucial role in managing and optimizing the pharmaceutical benefits provided to plan members or employees. Pharmacy benefit management acts as intermediaries between pharmacies, drug manufacturers, and healthcare payers, facilitating the effective and efficient delivery of prescription medications. It performs various functions, including negotiating drug prices with pharmaceutical companies, developing, and maintaining formularies, processing prescription claims, and managing pharmacy networks. Pharmacy benefit management aims to control prescription drug costs, promote generic drug utilization, ensure medication safety, and improve overall health outcomes.
Japan Pharmacy Benefit Management Market Trends:
In the Japan market, the driving force behind its growth lies in the imperative need for effective management of prescription drug costs. Additionally, the increasing pricing of medications has intensified the demand for pharmacy benefit management (PBM) services among health insurance providers, creating attractive opportunities for market expansion. Furthermore, the presence of similar drugs with slight variations in their active pharmaceutical ingredients (API) has heightened price sensitivity among consumers, resulting in a heightened demand for PBM services. Furthermore, the incorporation of machine learning (ML) and artificial intelligence (AI) technologies has played a pivotal role in enhancing operational efficiency. These technologies have streamlined supply chain processes, facilitated swifter order delivery, and catered to multiple insurance and retail pharmacy chains within limited timeframes. Additionally, there is a noticeable shift towards pharmacy benefit management systems due to their capacity to provide enhanced expertise and establish connections with leading companies. Furthermore, ongoing enhancements and the increasing availability of healthcare data are instigating significant transformations within the regional market. Apart from this, PBMs are harnessing the potential of data analytics, artificial intelligence, and machine learning to offer more personalized, data-driven pharmacy benefit solutions, which is expected to fuel the market growth in the coming years.
Japan Pharmacy Benefit Management Market Segmentation:
Service Insights:
- Specialty Pharmacy Services
- Drug Formulary Management
- Retail Pharmacy Services
- Benefit Plan Design and Consultation
- Disease Management Services
- Others
Business Model Insights:
- Health Insurance Management
- Standalone PBMs
- Retail Pharmacy
End Use Insights:
- Federal
- Commercial
Regional Insights:
- Kanto Region
- Kansai/Kinki Region
- Central/ Chubu Region
- Kyushu-Okinawa Region
- Tohoku Region
- Chugoku Region
- Hokkaido Region
- Shikoku Region
- The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan pharmacy benefit management market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan pharmacy benefit management market?
- What is the breakup of the Japan pharmacy benefit management market on the basis of service?
- What is the breakup of the Japan pharmacy benefit management market on the basis of business model?
- What is the breakup of the Japan pharmacy benefit management market on the basis of end use?
- What are the various stages in the value chain of the Japan pharmacy benefit management market?
- What are the key driving factors and challenges in the Japan pharmacy benefit management?
- What is the structure of the Japan pharmacy benefit management market and who are the key players?
- What is the degree of competition in the Japan pharmacy benefit management market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Pharmacy Benefit Management Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Pharmacy Benefit Management Market Landscape
- 5.1 Historical and Current Market Trends (2020-2025)
- 5.2 Market Forecast (2026-2034)
6 Japan Pharmacy Benefit Management Market - Breakup by Service
- 6.1 Specialty Pharmacy Services
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
- 6.2 Drug Formulary Management
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
- 6.3 Retail Pharmacy Services
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
- 6.4 Benefit Plan Design and Consultation
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)
- 6.5 Disease Management Services
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2020-2025)
- 6.5.3 Market Forecast (2026-2034)
- 6.6 Others
- 6.6.1 Historical and Current Market Trends (2020-2025)
- 6.6.2 Market Forecast (2026-2034)
7 Japan Pharmacy Benefit Management Market - Breakup by Business Model
- 7.1 Health Insurance Management
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
- 7.2 Standalone PBMs
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)
- 7.3 Retail Pharmacy
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2020-2025)
- 7.3.3 Market Forecast (2026-2034)
8 Japan Pharmacy Benefit Management Market - Breakup by End Use
- 8.1 Federal
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
- 8.2 Commercial
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
9 Japan Pharmacy Benefit Management Market - Breakup by Region
- 9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Service
- 9.1.4 Market Breakup by Business Model
- 9.1.5 Market Breakup by End Use
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
- 9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Service
- 9.2.4 Market Breakup by Business Model
- 9.2.5 Market Breakup by End Use
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
- 9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Service
- 9.3.4 Market Breakup by Business Model
- 9.3.5 Market Breakup by End Use
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
- 9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Service
- 9.4.4 Market Breakup by Business Model
- 9.4.5 Market Breakup by End Use
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
- 9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Service
- 9.5.4 Market Breakup by Business Model
- 9.5.5 Market Breakup by End Use
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
- 9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Service
- 9.6.4 Market Breakup by Business Model
- 9.6.5 Market Breakup by End Use
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
- 9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Service
- 9.7.4 Market Breakup by Business Model
- 9.7.5 Market Breakup by End Use
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
- 9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Service
- 9.8.4 Market Breakup by Business Model
- 9.8.5 Market Breakup by End Use
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)
10 Japan Pharmacy Benefit Management Market - Competitive Landscape
- 10.1 Overview
- 10.2 Market Structure
- 10.3 Market Player Positioning
- 10.4 Top Winning Strategies
- 10.5 Competitive Dashboard
- 10.6 Company Evaluation Quadrant
11 Profiles of Key Players
- 11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Services Offered
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
- 11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Services Offered
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
- 11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Services Offered
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
- 11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Services Offered
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
- 11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Services Offered
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events
12 Japan Pharmacy Benefit Management Market - Industry Analysis
- 12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
- 12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
- 12.3 Value Chain Analysis
